2-4-3--5--tetramethoxystilbene and Prostatic-Neoplasms

2-4-3--5--tetramethoxystilbene has been researched along with Prostatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for 2-4-3--5--tetramethoxystilbene and Prostatic-Neoplasms

ArticleYear
Induction of p27(kip1) by 2,4,3',5'- tetramethoxystilbene is regulated by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells.
    Archives of pharmacal research, 2008, Volume: 31, Issue:9

    trans-Stilbenes induce cytochrome P450 1B1 (CYP1B1) inhibition and cell death. 2,4,3',5' tetramethoxystilbene (TMS), a synthetic trans-stilbene analog, induced apoptotic cell death in PC-3 prostate cancer cells, as evidenced by a decrease in the mitochondrial membrane potential. TMS-induced apoptosis was associated with an increase in the level of cell cycle inhibitor, p27(kip1), through reduction of Akt-mediated Skp2 expression. TMS-induced activation of protein phosphatase 2A (PP2A) inhibited Akt phosphorylation and p27(kip1) expression, indicating that PP2A is involved in the induction of p27(kip1) via Akt inhibition. These results suggest that TMS may inhibit the cell cycle through induction of p27(kip1), leading to apoptotic cell death in PC-3 prostate cancer cells.

    Topics: Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; DNA, Complementary; Flow Cytometry; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Male; Membrane Potentials; Mitochondrial Membranes; Oncogene Protein v-akt; Phosphorylation; Prostatic Neoplasms; Protein Phosphatase 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; S-Phase Kinase-Associated Proteins; Stilbenes; Transfection

2008